Article
Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinib
2024-10-23
Abstract excerpt
<title>Abstract</title> <p>Juvenile dermatomyositis (JDM) is a rare autoimmune disorder affecting children, mainly characterized by skin rash and muscle weakness (1). Anti-MDA5 antibody-positive JDM represents a distinct phenotype of disease with a high risk of developing life-threatening progressive interstitial lung disease (ILD)(2). The pivotal role of the type I interferon (IFN) pathway in the pathogenesis of...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fd79564d-6744-5e38-9edd-bb2c51f0d5e3
- DOI
- 10.21203/rs.3.rs-4973421/v1
